Your browser doesn't support javascript.
loading
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Cigliano, Antonio; Zhang, Shanshan; Ribback, Silvia; Steinmann, Sara; Sini, Marcella; Ament, Cindy E; Utpatel, Kirsten; Song, Xinhua; Wang, Jingxiao; Pilo, Maria G; Berger, Fabian; Wang, Haichuan; Tao, Junyan; Li, Xiaolei; Pes, Giovanni M; Mancarella, Serena; Giannelli, Gianluigi; Dombrowski, Frank; Evert, Matthias; Calvisi, Diego F; Chen, Xin; Evert, Katja.
Afiliación
  • Cigliano A; Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, Germany.
  • Zhang S; Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
  • Ribback S; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, 513 Parnassus Avenue, San Francisco, CA, USA.
  • Steinmann S; Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Sini M; Institute of Pathology, University of Greifswald, Greifswald, Germany.
  • Ament CE; Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, Germany.
  • Utpatel K; Experimental Pathology Unit, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Song X; Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, Germany.
  • Wang J; Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, Germany.
  • Pilo MG; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, 513 Parnassus Avenue, San Francisco, CA, USA.
  • Berger F; School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Wang H; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, 513 Parnassus Avenue, San Francisco, CA, USA.
  • Tao J; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
  • Li X; Institute of Pathology, University of Greifswald, Greifswald, Germany.
  • Pes GM; Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, Germany.
  • Mancarella S; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, 513 Parnassus Avenue, San Francisco, CA, USA.
  • Giannelli G; Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Dombrowski F; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, 513 Parnassus Avenue, San Francisco, CA, USA.
  • Evert M; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, 513 Parnassus Avenue, San Francisco, CA, USA.
  • Calvisi DF; Department of Thyroid and Breast Surgery, The 960th Hospital of the PLA, Jinan, 250031, China.
  • Chen X; Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
  • Evert K; National Institute of Gastroenterology "S. de Bellis", Research Hospital, Castellana Grotte, Italy.
J Exp Clin Cancer Res ; 41(1): 192, 2022 Jun 03.
Article en En | MEDLINE | ID: mdl-35655220

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Colangiocarcinoma / Carcinoma Hepatocelular Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Colangiocarcinoma / Carcinoma Hepatocelular Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Alemania